Welcome!

News Feed Item

Diarrhea Global Clinical Trials Review, H1, 2013

NEW YORK, May 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Diarrhea Global Clinical Trials Review, H1, 2013
http://www.reportlinker.com/p0829678/Diarrhea-Global-Clinical-Trials-Review-H1-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Diarrhea Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, "Diarrhea Global Clinical Trials Review, H1, 2013" provides data on the Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diarrhea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diarrhea. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Diarrhea 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Diarrhea 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Diarrhea Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Sanofi 34
Clinical Trial Overview of Sanofi 34
Optimer Pharmaceuticals, Inc. 35
Clinical Trial Overview of Optimer Pharmaceuticals, Inc. 35
Salix Pharmaceuticals, Inc. 36
Clinical Trial Overview of Salix Pharmaceuticals, Inc. 36
Romark Laboratories, L.C. 37
Clinical Trial Overview of Romark Laboratories, L.C. 37
Johnson & Johnson 38
Clinical Trial Overview of Johnson & Johnson 38
Intercell AG 39
Clinical Trial Overview of Intercell AG 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Ipsen S.A. 41
Clinical Trial Overview of Ipsen S.A. 41
Glenmark Pharmaceuticals Ltd. 42
Clinical Trial Overview of Glenmark Pharmaceuticals Ltd. 42
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Mead Johnson Nutrition Company 44
Clinical Trial Overview of Mead Johnson Nutrition Company 44
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
AGI Therapeutics plc 46
Clinical Trial Overview of AGI Therapeutics plc 46
NIZO food research BV 47
Clinical Trial Overview of NIZO food research BV 47
Ventria Bioscience 48
Clinical Trial Overview of Ventria Bioscience 48
Bio-K+ International Inc. 49
Clinical Trial Overview of Bio-K+ International Inc. 49
Furiex Pharmaceuticals, Inc. 50
Clinical Trial Overview of Furiex Pharmaceuticals, Inc. 50
Friesland Coberco Dairy Foods Holding N.V. 51
Clinical Trial Overview of Friesland Coberco Dairy Foods Holding N.V. 51
Genzyme Corporation 52
Clinical Trial Overview of Genzyme Corporation 52
Nestle SA 53
Clinical Trial Overview of Nestle SA 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
ICDDR,B 54
Clinical Trial Overview of ICDDR,B 54
U.S. Centers for Disease Control and Prevention 55
Clinical Trial Overview of U.S. Centers for Disease Control and Prevention 55
International Vaccine Institute 56
Clinical Trial Overview of International Vaccine Institute 56
The University of Nottingham 57
Clinical Trial Overview of The University of Nottingham 57
The Johns Hopkins Bloomberg School of Public Health 58
Clinical Trial Overview of The Johns Hopkins Bloomberg School of Public Health 58
Aga Khan University 59
Clinical Trial Overview of Aga Khan University 59
Centro Pediatrico Albina de Patino 60
Clinical Trial Overview of Centro Pediatrico Albina de Patino 60
Johns Hopkins University 61
Clinical Trial Overview of Johns Hopkins University 61
University of Virginia 62
Clinical Trial Overview of University of Virginia 62
Mayo Clinic 63
Clinical Trial Overview of Mayo Clinic 63
Christian Medical College 64
Clinical Trial Overview of Christian Medical College 64
University of Pittsburgh 65
Clinical Trial Overview of University of Pittsburgh 65
Seoul National University Hospital 66
Clinical Trial Overview of Seoul National University Hospital 66
London School of Hygiene & Tropical Medicine 67
Clinical Trial Overview of London School of Hygiene & Tropical Medicine 67
Shanghai University of Traditional Chinese Medicine 68
Clinical Trial Overview of Shanghai University of Traditional Chinese Medicine 68
Centre for International Health 69
Clinical Trial Overview of Centre for International Health 69
The University of Texas Health Science Center at Houston 70
Clinical Trial Overview of The University of Texas Health Science Center at Houston 70
John D. Dingell VA Medical Center 71
Clinical Trial Overview of John D. Dingell VA Medical Center 71
Medical University of Warsaw 72
Clinical Trial Overview of Medical University of Warsaw 72
Hadassah Medical Organization 73
Clinical Trial Overview of Hadassah Medical Organization 73
Five Key Clinical Profiles 74
Appendix 123
Abbreviations 123
Definitions 123
Research Methodology 124
Secondary Research 124
About GlobalData 125
Contact Us 125
Disclaimer 125
Source 126

List of Tables

Diarrhea Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Diarrhea Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Diarrhea Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Diarrhea Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Diarrhea Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Diarrhea Therapeutics Clinical Trials, G7 Countries, 2013* 17
Diarrhea Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Diarrhea Therapeutics Clinical Trials, E7 Countries, 2013* 19
Diarrhea Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Diarrhea Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Diarrhea Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Diarrhea Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Diarrhea Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Diarrhea Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Diarrhea Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 34
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Optimer Pharmaceuticals, Inc., 2013* 35
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals, Inc., 2013* 36
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Romark Laboratories, L.C., 2013* 37
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 38
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Intercell AG, 2013* 39
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 40
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2013* 41
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Glenmark Pharmaceuticals Ltd., 2013* 42
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 43
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mead Johnson Nutrition Company, 2013* 44
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 45
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by AGI Therapeutics plc, 2013* 46
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by NIZO food research BV, 2013* 47
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Ventria Bioscience, 2013* 48
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-K+ International Inc., 2013* 49
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Furiex Pharmaceuticals, Inc., 2013* 50
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Friesland Coberco Dairy Foods Holding N.V., 2013* 51
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2013* 52
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle SA, 2013* 53
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by ICDDR,B, 2013* 54
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Centers for Disease Control and Prevention, 2013* 55
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by International Vaccine Institute, 2013* 56
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Nottingham, 2013* 57
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins Bloomberg School of Public Health, 2013* 58
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2013* 59
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Centro Pediatrico Albina de Patino, 2013* 60
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 61
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2013* 62
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 63
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Christian Medical College, 2013* 64
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 65
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2013* 66
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2013* 67
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai University of Traditional Chinese Medicine, 2013* 68
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for International Health, 2013* 69
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at Houston, 2013* 70
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by John D. Dingell VA Medical Center, 2013* 71
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Warsaw, 2013* 72
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013* 73

List of Figures

Diarrhea Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Diarrhea Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Diarrhea Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Diarrhea Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Diarrhea Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Diarrhea Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Diarrhea Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Diarrhea Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Diarrhea Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Diarrhea Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Diarrhea Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Diarrhea Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
GlobalData Methodology 124

To order this report:
Drug_Discovery_and_Development Industry:
Diarrhea Global Clinical Trials Review, H1, 2013

__________________________
Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The security needs of IoT environments require a strong, proven approach to maintain security, trust and privacy in their ecosystem. Assurance and protection of device identity, secure data encryption and authentication are the key security challenges organizations are trying to address when integrating IoT devices. This holds true for IoT applications in a wide range of industries, for example, healthcare, consumer devices, and manufacturing. In his session at @ThingsExpo, Lancen LaChance, vic...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
When you focus on a journey from up-close, you look at your own technical and cultural history and how you changed it for the benefit of the customer. This was our starting point: too many integration issues, 13 SWP days and very long cycles. It was evident that in this fast-paced industry we could no longer afford this reality. We needed something that would take us beyond reducing the development lifecycles, CI and Agile methodologies. We made a fundamental difference, even changed our culture...
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smart...
The Internet of Things can drive efficiency for airlines and airports. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Sudip Majumder, senior director of development at Oracle, discussed the technical details of the connected airline baggage and related social media solutions. These IoT applications will enhance travelers' journey experience and drive efficiency for the airlines and the airports.
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settle...
In his general session at 18th Cloud Expo, Lee Atchison, Principal Cloud Architect and Advocate at New Relic, discussed cloud as a ‘better data center’ and how it adds new capacity (faster) and improves application availability (redundancy). The cloud is a ‘Dynamic Tool for Dynamic Apps’ and resource allocation is an integral part of your application architecture, so use only the resources you need and allocate /de-allocate resources on the fly.
Containers have changed the mind of IT in DevOps. They enable developers to work with dev, test, stage and production environments identically. Containers provide the right abstraction for microservices and many cloud platforms have integrated them into deployment pipelines. DevOps and Containers together help companies to achieve their business goals faster and more effectively. In his session at DevOps Summit, Ruslan Synytsky, CEO and Co-founder of Jelastic, reviewed the current landscape of D...
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).